The impact of additional pertussis vaccine doses on disease incidence in children and infants

Vaccine

Volumn 29, Issue 2, 2010, Pages 207-211

  Stein Zamir, Chen ^a   Shoob, Hanna ^a   Abramson, Nitza ^a   Zentner, Gary ^a  

^a MINISTRY OF HEALTH   (Israel)

Author keywords

Children; Epidemiology; Pertussis; Prevention; Vaccination schedule

Indexed keywords

BACTERIAL VACCINE; DIPHTHERIA HEMOPHILUS INFLUENZA B PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; DISEASE TRANSMISSION; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT DISEASE; ISRAEL; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION; VIRUS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INCIDENCE; INFANT; INFANT, NEWBORN; ISRAEL; MALE; MIDDLE AGED; PERTUSSIS VACCINE; WHOOPING COUGH; YOUNG ADULT;

EID: 78649699242     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.10.058     Document Type: Article

References (30)

1. Edwards K.M., Decker M.D., Mortimer E.A. Pertussis vaccine. Vaccines 2008, 293-344. Saunders, Philadelphia. S.A. Plotkin, W.A. Orenstein, P.A. Offit (Eds.).
2. Bamberger E.S., Srugo I. What is new in pertussis?. Eur J Pediatr 2008, 167(2):133-139.
3. Heininger U. Update on pertussis in children. Expert Rev Anti Infect Ther 2010, 8(2):163-173.
4. Crowcroft N.S., Stein C., Duclos P., Birmingham M. How best to estimate the global burden of pertussis?. Lancet Infect Dis 2003, 3:413-418.
5. Pertussis vaccines. Wkly Epidemiol Rec 1999, 74(May (18)):137-143.
6. WHO vaccine-preventable diseases: monitoring system - 2008 global summary. 20-21, Pertussis. ). http://www.who.int/immunization_monitoring%20/data/en/.
7. von König C.H., Halperin S., Riffelmann M., Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002, 2(12):744-750.
8. Pertussis surveillance report 2003-2007. http://www.euvac.net/graphics/euvac/pdf/pertussis2.pdf.
9. Crowcroft N.S., Pebody R.G. Recent developments in pertussis. Lancet 2006, 367(9526):1926-1936.
10. Broder K.R., Cortese M.M., Iskander J.K., Kretsinger K., Slade B.A., Brown K.H., et al. Advisory Committee on Immunization Practices (ACIP). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006, 55(March (RR-3)):1-34.
11. Moerman L., Leventhal A., Slater P.E., Anis E., Yishai R., Marva E. The re-emergence of pertussis in Israel. Isr Med Assoc J 2006, 8(5):308-311.
12. Centers for Disease Control and Prevention (CDC) Pertussis-United States, 2001-2003. MMWR Morb Mortal Wkly Rep 2005, 54(December (50)):1283-1286.
13. Israel Center for Disease Control, Ministry of Health, Israel. Notifiable infectious diseases in Israel-54 years of surveillance. Publication No. 245. Jerusalem; 2006.
14. Centers for Disease Control and Prevention Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep Recomm Rep 1997, 46(RR-10):31-50.
15. Giammanco A., Nardone A., Pebody R., Kafatos G., Andrews N., Chiarini A., et al. European Sero-Epidemiology Network 2: standardization of immunoassay results for pertussis requires homogeneity in the antigenic preparations. Vaccine 2008, 26(35):4486-4493.
16. Population of Israel and Jerusalem by population group, 1922-2006. Statistical yearbook of Jerusalem no. 22: 2006/2007. Jerusalem 2008, Available at:. http://www.jiis.org.il/, M. Choshen (Ed.).
17. Ministry of Health Israel, Public Health Services, Department of Epidemiology. Weekly epidemiological reports. Available at: http://www.health.gov.il/.
18. Statistical Package for the Social Sciences (SPSS) 14.0 for Windows 2005, SPSS Inc., Chicago, IL.
19. WINPEPI® (R), Abramson JH. PEPI-for-Windows: computer programs for epidemiologists. Epidemiol Perspect Innov 2004;1:6.
20. Forsyth K.D., Wirsing von Konig C.H., Tan T., Caro J., Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007, 25(14):2634-2642.
21. Greenberg D.P., Doemland M., Bettinger J.A., Scheifele D.W., Halperin S.A., IMPACT Investigators, et al. Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States. Pediatr Infect Dis J 2009, 28(6):521-528.
22. Cortese M.M., Baughman A.L., Zhang R., Srivastava P.U., Wallace G.S. Pertussis hospitalizations among infants in the United States, 1993 to 2004. Pediatrics 2008, 121(3):484-492.
23. Greenberg D., Bamberger E., Ben-Shimol S., Gershtein R., Golan D., Srugo I. Pertussis is under diagnosed in infants hospitalized with lower respiratory tract infection in the pediatric intensive care unit. Med Sci Monit 2007, 13(11):CR475-CR480.
24. Walsh P., Overmeyer C., Kimmel L., Feola M., Pusavat J., Nguyen T.A., et al. Prevalence of Bordetella pertussis and Bordetella parapertussis in samples submitted for RSV screening. West J Emerg Med 2008, 9(August (3)):135-140.
25. Murphy T.V., Slade B.A., Broder K.R., Kretsinger K., Tiwari T., Joyce P.M., et al. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants; recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008, 57(May (RR-4)):1-51.
26. Wood N., McIntyre P., Marshall H., Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010, 29(3):209-215.
27. Knuf M., Schmitt H.J., Jacquet J.M., Collard A., Kieninger D., Meyer C.U., et al. Booster vaccination after neonatal priming with acellular pertussis vaccine. J Pediatr 2010, 156(4):675-678.
28. Long S.S. Bad news for neonatal pertussis vaccination. The Editors' perspective. J Pediatr 2010, 156(4):A2.
29. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009-conclusions and recommendations. Wkly Epidemiol Rec 2009, 84(50):517-532.
30. Rendi-Wagner P., Tobias J., Moerman L., Goren S., Bassal R., Green M., et al. The seroepidemiology of Bordetella pertussis in Israel-estimate of incidence of infection. Vaccine 2010, 28(19):3285-3290.